Itamar Medical – executive interview

Itamar Medical – executive interview

Itamar Medical (Nasdaq: ITMR and TASE: ITMR) is a medical device company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders. Itamar Medical commercializes a digital healthcare platform to facilitate the continuum of care for the effective management of sleep apnea. Itamar Medical offers a total sleep solution to help physicians provide comprehensive sleep apnea management in the home environment, eliminating the need to attend a clinic, thus optimizing patient care and reducing healthcare system costs.

In Edison’s Israel office, we interview Gilad Glick, Itamar Medical’s president and CEO, to update us on how the business has adapted to the COVID-19 environment as well as an update on Itamar’s record second quarter results.


You may also be interested in these:

Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.